CEP104

protein-coding

centrosomal protein 104, the group of Cilia and flagella associated|TOG domain containing

Gene summary

This gene encodes a centrosomal protein required for ciliogenesis and for ciliary tip structural integrity. The mammalian protein contains three amino-terminal hydrophobic domains, two glycosylation sites, four cysteine-rich motifs, and two regions with homology to the glutamate receptor ionotropic, NMDA 1 protein. During ciliogenesis, the encoded protein translocates from the distal tips of the centrioles to the tip of the elongating cilium. Knockdown of the protein in human retinal pigment cells results in severe defects in ciliogenesis with structural deformities at the ciliary tips. Allelic variants of this gene are associated with the autosomal-recessive disorder Joubert syndrome, which is characterized by a distinctive mid-hindbrain and cerebellar malformation, oculomotor apraxia, irregular breathing, developmental delay, and ataxia. [provided by RefSeq, Feb 2016]

Previous symbols:
  • KIAA0562

MANE transcript

NM_014704.4

Inheritance

AR

ClinVar variants

P:61U:221B:165

Top phenotype

Intellectual developmental disorder, autosomal recessive 77

gnomAD constraint

pLI —, LoF o/e 0.54

Max pathogenic AF

—

Genomic locus

chr1:3,812,086-3,857,396

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~45.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Joubert syndrome 25DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014770

Submitter: G2P

ciliopathyDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0005308

Submitter: ClinGen

The *CEP104* gene is located on chromosome 1 at 1p36.32 and encodes the centrosomal protein 104kDa. The protein contains an IFT25/APC10-like domain, two coiled-coil domains, a tumor overexpressed gene domain, four zinc finger domains, and an SxIP motif. This centrosomal protein is required for ciliogenesis and for ciliary tip structural integrity. Nagase et al. (1998) screened large proteins expressed in the brain with RT-PCR analysis and detected variable expression in all human tissues examined, with highest levels in kidney and skeletal muscle. Multiple disease entities have been reported in association with this gene, including autosomal recessive Joubert syndrome and autosomal recessive intellectual developmental disorder. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was no evidence of differences in their molecular mechanism, inheritance pattern, or phenotypic spectrum. Therefore, these disease entities have been lumped into one disease entity: autosomal recessive ciliopathy: MONDO:0005308. The *CEP104* gene was first reported in relation to autosomal recessive Joubert syndrome in 2015 (Srour et al., PMID: 26477546). Patients with *CEP104* gene variants have been reported to have a distinctive cerebellar and brain stem malformation (known as the molar tooth sign), hypotonia, and developmental delays which are the three primary features of Joubert syndrome. In addition, individuals with *CEP104* variants have also been reported to have oculomotor apraxia and intellectual disability. At least 9 variants (nonsense, frameshift, splice site) have been reported in 9 probands across 4 publications (PMIDs: 26477546, 31625690, 34196201, 35359234 included in this curation). The mechanism of pathogenicity is known to be loss of function. A maximum score of 12 pts. genetic evidence was reached, considering case-level data and segregation data. This gene-disease relationship is also supported by expression studies, functional studies, in vitro assays in non-patient cells, and animal models. The scored expression data include the detection of cloned *CEP104* (known as Glybp) in rat cortex, hippocampus, cerebellum, and brainstem tissue (Kumar et al., PMID: 7488117). In addition, another expression study noted cloned human *CEP104* (known as KIAA0562) in all human tissues examined, with highest levels in kidney and skeletal muscle (Nagase et al., PMID: 9628581). The scored functional evidence involves RNAi experiments with *CEP104*-depleted cultures of human RPE1 retinal pigment epithelial cells to demonstrate a loss of *CEP104* staining at the tip of the primary cilium and daughter centriole, significant reduction in cilia formation, and significant reduction in length of cilia which supports the hypothesis that *CEP104* is required for ciliogenesis (Satish Tammana, et al., PMID: 23970417). Frikstad et al. showed that *CEP104* silencing in zebrafish causes cilia-related manifestations, including a shortened cilia in Kupffer's vesicle, heart laterality, and cranial nerve development defects. This study also completed in vivo and in vitro analyses of *CEP104* and its interaction with another Joubert syndrome-associated cilia tip protein, CSPP1. The loss of *CEP104* or CSPP1 in human cells leads to defective Hedgehog signaling in cilia (Frikstad et al., PMID: 31412255). A total of 4.5 pts. experimental evidence was reached. In summary, there is definitive evidence supporting the relationship between *CEP104* and autosomal recessive ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date May 13th, 2024 (SOP Version 11).

Joubert syndrome 25MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014770

Submitter: Ambry Genetics

Joubert syndrome 25STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014770

Submitter: Labcorp Genetics (formerly Invitae)

Joubert syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0018772

Submitter: Orphanet

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal recessive 77AR

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 34196201; 35359234Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CEP104 variants in ClinVar

17 Conditions Cataloged
Joubert syndrome 25Total: 295
not providedTotal: 176
not specifiedTotal: 166
Inborn genetic diseasesTotal: 148
CEP104-related disorderTotal: 46
Intellectual developmental disorder, autosomal recessive 77Total: 26
CEP104-related disordersTotal: 16
Joubert syndrome and related disordersTotal: 14

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014704.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
114
clinvar
2
clinvar
119
missense
1
clinvar
206
clinvar
45
clinvar
1
clinvar
253
nonsense
4
clinvar
15
clinvar
1
clinvar
20
start loss
0
frameshift
11
clinvar
16
clinvar
1
clinvar
28
splice donor/acceptor (+/-2bp)
2
clinvar
12
clinvar
10
clinvar
1
clinvar
2
clinvar
27
Total18432211605447

Highest pathogenic variant AF is 0.00040422552

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 60 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014704.4RefSeqNP_055519.121MANE Select
ENST00000378230.8EnsemblENSP00000367476.321MANE Select
ENST00000378223.3EnsemblENSP00000367468.36Standard
ENST00000378223.4EnsemblENSP00000367468.36Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Molecular Function

  • protein binding
  • glycine binding
  • glutamate binding
  • thienylcyclohexylpiperidine binding

Cellular Component

  • spindle pole
  • centriole
  • cilium

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000378230
Coding exons
21
Length
45134
Individuals with no LoFs
125617
Homozygous LoFs
0
Heterozygous LoFs
131
Defined
125748
p
0.000521
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.4445035320.9460.00003126046
Missense (PolyPhen)144176.070.817842011
Synonymous1.651712010.8520.00001261737
Loss of Function3.052851.70.5420.00000291604

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000490.00049rare
Latino/Admixed American0.000270.00026rare
Ashkenazi Jewish0.000200.00020rare
East Asian0.000160.00016rare
Finnish0.000510.00051rare
European (Non-Finnish)0.000780.00078rare
South Asian0.000230.00023rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Required for ciliogenesis and for structural integrity at the ciliary tip. {ECO:0000269|PubMed:23970417}.;
Disease
DISEASE: Joubert syndrome 25 (JBTS25) [MIM:616781]: A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS25 clinical manifestations appear to be confined to the neurologic system. JBTS25 inheritance is autosomal recessive. {ECO:0000269|PubMed:26477546}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

RVIS EVS
-0.15
RVIS percentile EVS
42.34

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.